1. Chronic myelomonocytic leukemia (CMML)

   • Klaus Geissler

   editorial 25 January 2023 Pages: 1 - 2

2. Significance of reduced renal function in patients with chronic myelomonocytic leukemia

   • Julia Heschl
   • Klaus Geissler

   main topic Open access 25 October 2022 Pages: 3 - 8

   

3. Significance of abnormal blood coagulation in patients with chronic myelomonocytic leukemia

   • Christoph Weinfurtner
   • Klaus Geissler

   main topic Open access 07 October 2022 Pages: 9 - 14

   

4. Significance of C-reactive protein in patients with chronic myelomonocytic leukemia

   • Jian Liang-Fonseca
   • Klaus Geissler

   main topic Open access 28 November 2022 Pages: 15 - 20

   

5. Significance of hypergammaglobulinemia in patients with chronic myelomonocytic leukemia

   • Marie-Therese Zack
   • Klaus Geissler

   main topic Open access 29 November 2022 Pages: 21 - 26

   

6. Significance of cardiovascular comorbidity in patients with chronic myelomonocytic leukemia

   • David Lackner
   • Klaus Geissler

   main topic Open access 21 November 2022 Pages: 27 - 33

   

7. Treatment options and survival in real life during the past three decades in patients with chronic myelomonocytic leukemia

   • Julia Reiser
   • Klaus Geissler

   main topic Open access 25 October 2022 Pages: 34 - 40

   

8. Hashimoto’s thyroiditis and coexisting disorders in correlation with HLA status—an overview

   • Peter Mikosch
   • Adrian Aistleitner
   • Eva Trifina-Mikosch

   review Open access 15 September 2021 Pages: 41 - 53

   

9. Erworbene Hemmkörperhämophilie

   • Christoph Sucker
   • Ursula Schmitt
   • Jens Litmathe

   fallbericht 02 August 2021 Pages: 54 - 56